Signaling Pathways Targeting Colorectal Cancer in Egypt

CompletedOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

January 1, 2020

Study Completion Date

April 1, 2020

Conditions
Colorectal Cancer
Interventions
GENETIC

Markers in tissue samples: (TIGAR , TRIM59, P53, AKT, GSH)

"The followings markers will be investigated in tissue samples:~1. TIGAR expression using quantitative real-time polymerase chain reaction (q Rt PCR) and immunohistochemistry.~2. TRIM59 expression using quantitative real-time polymerase chain reaction (q Rt PCR) and immunohistochemistry.~P53 expression using immunohistochemistry. P53 nuclear localization is essential for its normal function in growth inhibition or induction of apoptosis.~* Akt expression using western blot.~* GSH using chemical methods."

Trial Locations (1)

71111

Assiut University- faculty of medicine -Medical biochemistry department, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03467308 - Signaling Pathways Targeting Colorectal Cancer in Egypt | Biotech Hunter | Biotech Hunter